Ulf Wiinberg

Sits on 2 boards. Last updated September 28, 2026

Time on boards

Boards served
2
Current seats
2
Board service
7 years
Director since
2023

7 years of board service in total across 2 boards, counting each seat separately. Longest: Agenus Inc., 3 years.

Agenus Inc. Director
3 years · Since 2023
3 years · Since 2023

Shareholder support

Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Sep 1, 2026 MiNK Therapeutics Inc. Grant or award +1,279 $10.95 $14,005
Jun 1, 2026 MiNK Therapeutics Inc. Grant or award +1,131 $12.38 $14,002
Mar 2, 2026 MiNK Therapeutics Inc. Grant or award +1,285 $10.90 $14,007
Dec 1, 2025 MiNK Therapeutics Inc. Grant or award +1,263 $11.09 $14,007
Sep 2, 2025 MiNK Therapeutics Inc. Grant or award +1,011 $13.86 $14,012
Jun 2, 2025 MiNK Therapeutics Inc. Grant or award +1,953 $7.17 $14,003
Mar 3, 2025 MiNK Therapeutics Inc. Grant or award +1,593 $8.79 $14,002
Dec 1, 2024 MiNK Therapeutics Inc. Grant or award +20,476 $0.73 $14,947
Sep 3, 2024 MiNK Therapeutics Inc. Grant or award +18,295 $0.82 $15,002
Jun 3, 2024 MiNK Therapeutics Inc. Grant or award +15,077 $0.99 $14,926
Mar 1, 2024 MiNK Therapeutics Inc. Grant or award +15,790 $0.95 $15,001
Dec 1, 2023 MiNK Therapeutics Inc. Grant or award +14,424 $1.04 $15,001
Nov 15, 2023 Agenus Inc. Open-market purchase +25,000 $0.76 $19,000
Sep 1, 2023 MiNK Therapeutics Inc. Grant or award +9,590 $1.46 $14,001
Jun 1, 2023 MiNK Therapeutics Inc. Grant or award +7,955 $1.76 $14,001

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.